(Q28218738)

English

Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?

scientific article (publication date: March 2005)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors? (English)

0 references

1 reference

J Scheiman

1

0 references

language of work or name

English

0 references

publication date

March 2005

0 references

published in

Alimentary Pharmacology & Therapeutics

0 references

volume

21 Suppl 1

0 references

page(s)

7-8, 21-4

0 references

cites work

Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

A randomized trial of aspirin to prevent colorectal adenomas

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111/J.1365-2036.2004.02347.X

retrieved

21 April 2017

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02347.X

retrieved

21 January 2018

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02347.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1365-2036.2004.02347.X

0 references

PubMed ID

15755267

0 references

ResearchGate publication ID

7979626

0 references

(Q28218738)

Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)